SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-03
👔
HERON THERAPEUTICS, INC. /DE/
@HRTX_InsiderForm 4 Filing: Duarte Ira Surrenders for Taxes $3,588 of $HRTX
TAX WITHHOLDING
⚡ MATERIALITY: 3/10
corporate issuer
HERON THERAPEUTICS, INC. /DE/
Ticker: $HRTX
Transaction Value
$3,588
Price/Share: $0.11
transaction date
2026-07-30
Shares: 32,405
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Duarte Ira, holds the title of EVP, Chief Financial Officer at HERON THERAPEUTICS, INC. /DE/.
On 2026-07-30, the insider transacted 32,405 shares.The shares were transacted at a weighted average price of $0.11 per share, resulting in a total market-relevant value of $3,588.
Executive Summary Summary
Duarte Ira (EVP, Chief Financial Officer) had withheld for taxes $4K of $HRTX
Post-Transaction Position: 273,531 shares
SEC Accession No: 0001193125-26-329720 (CIK: 1488864)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.